Tech & AI
FDA orders vision-loss warning on GLP-1 drug labels
often permanent. How GLP-1 drugs might cause it is unknown, the outlet reports. The FDA describes the risk as potential, and Ars Technica reports it is unknown how GLP-1 drugs
Benjamin Scott2 min read
